Navigation Links
Halozyme Therapeutics Reports First Quarter 2011 Financial Results
Date:5/6/2011

SAN DIEGO, May 6, 2011 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the diabetes, cancer, dermatology and drug delivery markets, today reported financial results for the first quarter 2011.

(Logo: http://photos.prnewswire.com/prnh/20100302/LA63139LOGO)

"The faster insulin absorption and shorter duration of action observed in our first ultrafast insulin pump study is exciting," stated Gregory I. Frost, Ph.D., Halozyme's president and CEO. "Patients with diabetes that use insulin pumps could see unique benefits from Halozyme's Ultrafast Insulin."

First Quarter 2011 and Recent Business Highlights

  • Halozyme presented preliminary results from its first Ultrafast Insulin study in type 1 diabetes patients who receive their treatment with an insulin pump demonstrating that Aspart-PH20 generates a faster-in and faster-out profile with accelerated insulin absorption and a shorter duration of action compared to aspart alone. Aspart-PH20 is a formulation of Halozyme's rHuPH20 (recombinant human hyaluronidase) enzyme with the active ingredient in NovoLog® that was administered as a continuous subcutaneous insulin infusion over 72 hours with an insulin pump. Halozyme presented these results at the American Association of Clinical Endocrinologists meeting in San Diego on April 14, 2011.  
  • American Diabetes Association (ADA) 71s
    '/>"/>

  • SOURCE Halozyme Therapeutics, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related biology technology :

    1. Halozymes Ultrafast Insulin Generates Faster-In and Faster-Out Profile for Type 1 Diabetes Patients Using Insulin Pumps
    2. Halozyme Announces Roche Doses First Patient in Phase 3 Clinical Trial With Subcutaneous MabThera® (rituximab)
    3. Halozyme Therapeutics Reports Third Quarter 2010 Financial Results
    4. Halozyme Receives $5.5 Million Payment From Baxter
    5. Halozyme Therapeutics Reports 2008 Third Quarter Financial Results
    6. Halozyme Therapeutics Begins Phase 2 Clinical Trial of Insulin With rHuPH20 in Type 1 Diabetic Patients
    7. Halozyme Therapeutics Announces Conference Call on November 6 to Review Third Quarter Results
    8. Halozyme Therapeutics to Present at Upcoming Investor Conferences
    9. Halozyme Therapeutics to Host Research Day for Investors and Analysts
    10. Halozyme Therapeutics Appoints Head of Endocrinology Clinical Development
    11. Halozyme Therapeutics to Present at Upcoming Investor Conferences
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/25/2014)... Research and Markets  has announced ... 2014-2018" report to their offering. ... or Metabonomics is the scientific study of chemical ... experimental technique that is being widely used in ... small molecules that are present in blood, urine, ...
    (Date:7/25/2014)... San Diego, CA (PRWEB) July 25, 2014 ... “Paws” For Your Pet with Lorry Young will be ... DVM, to talk about stem cell therapy in pets. ... discuss the benefits of stem cell therapy for pets suffering ... developments moving the Regenerative Veterinary Medicine industry forward. , Young ...
    (Date:7/25/2014)... Livermore, California (PRWEB) July 25, 2014 ... been named to Thomson Reuters list of " The ... Pitz are part of the 3,000 researchers who were ... years to recognize those who published the highest-impact work ... numerous research papers on combustion modeling . , ...
    (Date:7/25/2014)... , July 25, 2014 /PRNewswire-iReach/ -- Xybion ... consulting for global corporations operating in highly regulated ... its first annual Global User Group Conference, Xybion ... Philadelphia, Pennsylvania at the ... http://photos.prnewswire.com/prnh/20140724/130263 This year,s ...
    Breaking Biology Technology:Global Metabolomics Market 2014-2018: Key Vendors are Agilent, Bio-Rad, Bruker, Human Metabolome and Metabolon 2Robert J. Harman, DVM, Founder and CEO of Vet-Stem, Inc. to Join New York Radio Host Lorry Young in Upcoming Episode of A “Paws” For Your Pet 2Robert J. Harman, DVM, Founder and CEO of Vet-Stem, Inc. to Join New York Radio Host Lorry Young in Upcoming Episode of A “Paws” For Your Pet 3Scientists Burst onto Influential List for Combustion Research 2Scientists Burst onto Influential List for Combustion Research 3Scientists Burst onto Influential List for Combustion Research 4Xybion Announces It Will Host International User Conference in Philadelphia 2Xybion Announces It Will Host International User Conference in Philadelphia 3
    ... North America, BURLINGTON, Mass., Jan. 9 ... leading researcher and developer of,light-based systems for cosmetic ... agreement with the Swedish company Q-MED,AB (OMX Nordic ... company based in Uppsala, Sweden. Q-MED will,eventually be ...
    ... SMA ), an independent provider of products to ... today that the board,of directors has voted to expand ... It has appointed two new independent directors, John S. ... the total of,independent directors to six., Mr. Krelle ...
    ... footprint in human health services around the ... ... new markets, SRA International, Inc. (NYSE: SRX ) today,announced the appointment of ... Chief Financial Officer (CFO) of its new,Global Health Sector (GHS) organization. GHS was ...
    Cached Biology Technology:Palomar and Q-MED AB Enter Into International Distribution Agreement 2Palomar and Q-MED AB Enter Into International Distribution Agreement 3Palomar and Q-MED AB Enter Into International Distribution Agreement 4Palomar and Q-MED AB Enter Into International Distribution Agreement 5Palomar and Q-MED AB Enter Into International Distribution Agreement 6Symmetry Medical Expands Board of Directors 2Symmetry Medical Expands Board of Directors 3SRA Names Timothy J. Atkin Senior Vice President of Global Health Business; Appoints Mike Toner Global Health Unit Chief Financial Officer 2SRA Names Timothy J. Atkin Senior Vice President of Global Health Business; Appoints Mike Toner Global Health Unit Chief Financial Officer 3
    (Date:7/24/2014)... Bushmeat, the use of native animal species for food ... be a significant factor in the decline of many ... new study indicates that more than half of the ... raptors and hornbills., "By surveying not only the meat ... being eaten inside the forest by hunters and brought ...
    (Date:7/24/2014)... Acoustic disturbance has different effects on different species ... the Universities of Bristol and Exeter which tested ... sooner to a flying seagull predator model when ... observed in European minnows. , Lead author ... Sciences said: "Noise levels in many aquatic environments ...
    (Date:7/24/2014)... cars ply silent freeways, solar panels blanket rooftops and ... from howling winds and from the blazing desert sun. ... technically and economically feasible to convert California,s all-purpose energy ... in Energy , the plan shows the way ... California that could create tens of thousands of jobs ...
    Breaking Biology News(10 mins):Stanford study shows how to power California with wind, water and sun 2Stanford study shows how to power California with wind, water and sun 3Stanford study shows how to power California with wind, water and sun 4
    ... turning up to an undergraduate class, being given a ... to improve on it. This was the ... College London,s) Department of Science and Technology Studies between ... to teaching is a full-blown academic monograph published this ...
    ... many historical stories of shepherds and travellers encountering lions, ... about attacks on flocks and people by these fierce ... former range, but for livestock owners around the Waza ... reality. Although loss of human life is rarely reported, ...
    ... mission to the Moon was launched today by the ... the Xichang Satellite Launch Centre, Sichuan, atop a Long ... in the Chinese ambition to land robotic explorers on ... goals to accomplish. The first is to make three-dimensional ...
    Cached Biology News:Living with lions 2Chang'e-1 -- new mission to Moon lifts off 2
    ... Phage Capture Plate is a 96-well ELISA-compatible plate ... T7 Tail Fiber Monoclonal Antibody is immobilized by ... antibody specifically recognizes the tail fiber protein of ... a capacity of 10 9 phage per ...
    ... TRAPeze RT Telomerase Detection Kit ... vitro assay for the fluorometric ... of telomerase activity. It incorporates ... assay and adds the ability ...
    ... Gene Pulser apparatus and accessory modules the most ... the Gene Pulser II system, which features unique ... Pulser II system has the dual advantages of ... of settings to target specific cell types and ...
    Caliper offers a wide array of standard LabChip products designed to be used in combination with our AMS 90 and LabChip 3000 microfluidic platforms....
    Biology Products: